<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01977560</url>
  </required_header>
  <id_info>
    <org_study_id>201302095</org_study_id>
    <nct_id>NCT01977560</nct_id>
  </id_info>
  <brief_title>Diet and Exercise Intervention in Type 2 Diabetes</brief_title>
  <acronym>LID</acronym>
  <official_title>Diet and Exercise Intervention in Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Dairy Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Egg Board</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of lifestyle intervention on metabolism
      and blood sugar control in Type 2 Diabetics.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2013</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemic Control</measure>
    <time_frame>8 months</time_frame>
    <description>This aim will be evaluated by assessment of: i) fasting plasma glucose; ii) glycated hemoglobin (HbA1c); iii) use of diabetes medications and iv) resolution of Type 2 diabetes, defined as a fasting plasma glucose &lt;126 mg/dL, 2-hr oral glucose tolerance test plasma glucose &lt;200 mg/dL, HbA1c &lt;6.5% and discontinuation of all diabetes medications.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glucose metabolism</measure>
    <time_frame>8 months</time_frame>
    <description>Liver and skeletal muscle insulin sensitivity, β-cell function, and cellular factors in skeletal muscle and adipose tissue that regulate glucose metabolism.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuronal Function</measure>
    <time_frame>8 months</time_frame>
    <description>This aim will be evaluated by assessing by administration of cognitive testing and brain MRI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability and Feasibility of Intervention</measure>
    <time_frame>8 months</time_frame>
    <description>This aim will be evaluated by using semi-structured interviews to assess accessibility and feasibility. In addition, participants' time spent on intervention activities will be determined.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Cardiovascular risk factors</measure>
    <time_frame>8 months</time_frame>
    <description>Plasma lipid profile; markers of inflammation, body fat distribution [visceral adipose tissue (VAT), intrahepatic triglyceride (IHTG) content and intramyocardial TG content], and cardiovascular structure and function.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This arm will receive standard care for Type 2 diabetes: exercise and diet counseling according to the American Diabetes Association recommendations.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimum Lifestyle intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will be participate in weekly visits with a dietitian and 4 weekly supervised exercise sessions. They will be advised to follow a high-protein, low-carbohydrate diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Optimum Lifestyle Intervention</intervention_name>
    <description>Participants will follow a high-protein, low-carbohydrate diet and participate in supervised exercise.</description>
    <arm_group_label>Optimum Lifestyle intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard Care</intervention_name>
    <description>Participants will be given advice on exercise and the American Diabetes Association diet, as if they went to a Diabetes clinic.</description>
    <arm_group_label>Standard Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 25-68 yrs old

          2. BMI 27.0-50.0 kg/m²

          3. Diagnosis of type 2 diabetes based on HbA1C&gt;6.5% or results of an oral glucose
             tolerance test or current use of anti-diabetic medications

          4. HbA1C ≤9.5 %.

          5. Work at Washington University in St. Louis, Barnes Jewish Hospital, St. Louis
             Children's Hospital, Shriners, St. Louis College of Pharmacy, Central Institute for
             the Deaf, Rehabilitation Institute of St. Louis, and/or any institutions affiliated
             with these.

        Exclusion Criteria:

          1. Any change in diabetes medication in previous 3 months

          2. Unstable weight (&gt;2% change during the last 2 months before entering the study)

          3. History or evidence of serious pulmonary or cardiovascular disease, including acute
             coronary syndrome, heart failure requiring medications, or New York Heart Association
             class III heart failure (patients with marked limitation of activity and who are
             comfortable only at rest) or IV heart failure (patients who should be at complete
             rest, confined to bed or chair and who have discomfort with any physical activity).

          4. Evidence of serious cardiac abnormalities during exercise stress testing that increase
             cardiac risk of initiating an exercise program.

          5. Creatinine &gt;1.5 mg/dL

          6. Microalbuminuria; spot urine albumin:creatinine ratio &gt;50 (50 μg albumin/mg
             creatinine)

          7. Coagulation disorders

          8. Anemia (Hemoglobin &lt;10.0 g/dL)

          9. Liver enzymes (ALT and AST) ≥3 times the upper limit of normal

         10. Uncontrolled proliferative diabetic retinopathy

         11. Severe peripheral neuropathy diagnosed by monofilament testing

         12. Severe organ dysfunction

         13. Pregnant or breastfeeding

         14. Participating in regular exercise (&gt;1 h of structured exercise/week)

         15. Joint replacement within the last year

         16. Smokes tobacco

         17. Severe lactose intolerance

         18. Take any medication that might interfere with interpretation of the metabolic studies

         19. Unable or unwilling to follow the study protocol or for any reason the research team
             believes the volunteer is not an appropriate candidate for this study, including
             non-compliance with screening appointments or previous medical visits.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>68 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Klein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2013</study_first_submitted>
  <study_first_submitted_qc>October 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2013</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Exercise</keyword>
  <keyword>High protein</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

